These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1674877)

  • 1. Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification.
    Meltzer P; Leibovitz A; Dalton W; Villar H; Kute T; Davis J; Nagle R; Trent J
    Br J Cancer; 1991 May; 63(5):727-35. PubMed ID: 1674877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.
    Tavassoli M; Quirke P; Farzaneh F; Lock NJ; Mayne LV; Kirkham N
    Br J Cancer; 1989 Oct; 60(4):505-10. PubMed ID: 2572268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
    van de Vijver MJ; Peterse JL; Mooi WJ; Wisman P; Lomans J; Dalesio O; Nusse R
    N Engl J Med; 1988 Nov; 319(19):1239-45. PubMed ID: 2903446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of amplification of the C-erb B2/Her-2/neu gene in human breast cancer].
    Sellami M; Gamoudi M; Krichen K; Kharrat A; Ben Romdhane K; Maalej M
    Arch Inst Pasteur Tunis; 1991; 68(1-2):33-41. PubMed ID: 1687309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.
    Tsuda H; Iwaya K; Fukutomi T; Hirohashi S
    Jpn J Cancer Res; 1993 Apr; 84(4):394-401. PubMed ID: 8099903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.
    Heintz NH; Leslie KO; Rogers LA; Howard PL
    Arch Pathol Lab Med; 1990 Feb; 114(2):160-3. PubMed ID: 1967929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [C-erbB-2 oncogene amplification in breast cancer in correlation to steroid and epidermal growth factor receptor].
    Manavi M; Czerwenka KF; Zeillinger R; Speiser P; Kury F; Steinhart U; Peschke M; Kubista E; Reinold E
    Zentralbl Gynakol; 1992; 114(2):82-5. PubMed ID: 1350129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
    Børresen AL; Ottestad L; Gaustad A; Andersen TI; Heikkilä R; Jahnsen T; Tveit KM; Nesland JM
    Br J Cancer; 1990 Oct; 62(4):585-90. PubMed ID: 1977466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK; Tjan S; Parkes RK; O'Malley FP
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
    Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis.
    Tiwari RK; Borgen PI; Wong GY; Cordon-Cardo C; Osborne MP
    Anticancer Res; 1992; 12(2):419-25. PubMed ID: 1349794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma.
    Naber SP; Tsutsumi Y; Yin S; Zolnay SA; Mobtaker H; Marks PJ; McKenzie SJ; DeLellis RA; Wolfe HJ
    Am J Clin Pathol; 1990 Aug; 94(2):125-36. PubMed ID: 1973590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER-2/neu oncogene: what does amplification mean?
    Pavy JJ; Descotes F; Adessi GL
    Br J Cancer; 1993 Jul; 68(1):214-5. PubMed ID: 8100444
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
    Escot C; Theillet C; Lidereau R; Spyratos F; Champeme MH; Gest J; Callahan R
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4834-8. PubMed ID: 3014513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the HER-2/neu proto-oncogene in human breast cancer.
    Slamon DJ
    Cancer Invest; 1990; 8(2):253. PubMed ID: 1976032
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
    Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR.
    Knyazev PG; Imyanitov EN; Chernitca OI; Nikiforova IF; Hanson KP
    Oncology; 1992; 49(2):162-5. PubMed ID: 1349430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proto-oncogene amplification and homogeneously staining regions in human breast carcinomas.
    Saint-Ruf C; Gerbault-Seureau M; Viegas-Péquignot E; Zafrani B; Cassingena R; Dutrillaux B
    Genes Chromosomes Cancer; 1990 May; 2(1):18-26. PubMed ID: 2177639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of the int-2 gene in primary human breast tumors.
    Lidereau R; Callahan R; Dickson C; Peters G; Escot C; Ali IU
    Oncogene Res; 1988 Feb; 2(3):285-91. PubMed ID: 2835739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of genetic status of HER-2/neu and aneusomy 17 by fluorescence in situ hybridization and comparison with immunohistochemistry assay from Indian breast cancer patients.
    Kokate P; Sawaimoon S; Bhatia S; Mandava S
    Genet Test Mol Biomarkers; 2012 Apr; 16(4):239-45. PubMed ID: 22023243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.